Table 4.
Secondary outcomes of the groups.
| Variables | Total |
Control group |
CHM group |
p | |||
|---|---|---|---|---|---|---|---|
| Mortality rate on Day 28 | N | No. (%) | N | No. (%) | N | No. (%) | |
| Survival | 86 | 75 (87%) | 43 | 34 (79%) | 43 | 41(95%) | 0.049 |
| Death | 86 | 11 (13%) | 43 | 9 (21%) | 43 | 2 (5%) | |
| Duration of main symptoms (days) | N | Median (IQR) | N | Median (IQR) | N | Median (IQR) | |
| Duration of fever | 29 | 5 (3.5–7.5) | 14 | 7 (5–9.3) | 15 | 4 (2–5) | 0.002 |
| Duration of cough | 76 | 18 (13.9–22.1) | 38 | 21 (13.0–29.0) | 38 | 16 (11.6–20.4) | 0.441 |
| Duration of dyspnea | 76 | 20 (15.4–24.5) | 36 | 20 (13.7–26.3) | 40 | 19 (12.6–25.4) | 0.793 |
| Lung lesion ratio from CT images | N | Percentage | N | Percentage | N | Percentage | |
| Before treatment | 55 | 30 ± 18 | 29 | 26 ± 16 | 26 | 35 ± 19 | 0.081 |
| After treatment | 55 | 29 ± 19 | 29 | 28 ± 18 | 26 | 29 ± 21 | 0.832 |
| Difference | 55 | 1 ± 18 | 29 | 2 ± 13 | 26 | 5 ± 22 | 0.267 |
CHM: Chinese herbal medicine.